• Hoovers Logo
    Insightful information about industries, companies, and the people who lead them.

    Learn More.
  • HELICOS BIOSCIENCES CORP Profile

    Helicos BioSciences is in the business of developing genetic analysis technologies. Its True Single Molecule Sequencing (tSMS) platform allows for the direct analysis of DNA and RNA samples without amplification, cloning, or other time-consuming preparation techniques. The company serves the research, clinical diagnostic, and drug discovery markets and aims to provide customers with the ability to compare thousands of samples. Its HeliScope genetic analysis system can be integrated into existing laboratories and consists of a computer-controlled instrument and related supplies and reagents.
    Stanley N. Lapidus
    CEO
    1 Kendall Sq., Bldg. 700

    Cambridge, MA 02139

    http://www.helicosbio.com

    Phone: 617-264-1800

    Fax: —
    Sector: Healthcare Industry: Drugs
  • 2007 Sales 2007 Sales Growth 2007 Net Income Employees
    $600,000 262.5% $-36,800,000
  • Key Executives: HLCS

    Name Title Officer Since
    Stanley N. Lapidus CEO 10/1/07
    Stephen J. Lombardi COO -
    Stephen P. Hall CFO -
    Dr. Noubar B. Afeyan, Ph.D. Director/Founder 1/1/03
    Louise A. Mawhinney -
    J. William Efcavitch, PhD Senior VP, Divisional -
    Brian G. Atwood Director 1/1/03
    Dr. Peter Barrett, Ph.D. Director 1/1/03
  • Top Competitors: HLCS

  • Insider Trends: HLCS

    Sentiment for HLCS is

    • 0M
    • 2M
    • 4M
    • 6M
    • Market Value of Insider Sales
    • Market Value of Insider Purchases
    Total dollar value of all insider purchases and sales over 12 months
  • Ownership Breakdown : HLCS

    Large Block Holder Type Number  
    Institutions 27.00
     
    Mutual Fund 23.00
    Other Major 5.00
  • Short Interest Volume: HLCS

    Data as of 6/25/08
    Current Short Interest Shares 301.99 M
    Current Short Interest Ratio 3.60
    Float 20.02 M
    Short Interest as % of Float 0.60
    Average Daily Volume 26,000.00
    Outstanding Shares 20.94 M